Source link : https://newshealth.biz/health-news/end-of-compounded-semaglutide-464m-teens-will-have-obesity-glp-1-scripts-skyrocket/
(MedPage Today) — A federal deadline ending the sale of compounded semaglutide (Ozempic, Wegovy) is now in effect after a similar one for tirzepatide (Mounjaro, Zepbound) passed in March. (U.S. News & World Report) A patient-delivered lifestyle… Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/115774 Author : Publish date : 2025-05-27 19:34:00 Copyright for syndicated content belongs to the […]
The post End of Compounded Semaglutide; 464M Teens Will Have Obesity; GLP-1 Scripts Skyrocket first appeared on News Health.
—-
Author : News Health
Publish date : 2025-05-27 19:34:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8